Small Bioactive Molecules in Early COPD Diseases

NCT04950023 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2021-07-14

No results posted yet for this study

Summary

To study the predictors contribute to the progression of COPD by follow-up of patients with early COPD and analyze their changes in bioactive molecular, exhaled gas, CT image, lung function, patient's symptoms and life quality.

Conditions

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Eligibility

Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-11
Primary Completion
2022-05-11
Completion
2024-05-11

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04950023 on ClinicalTrials.gov